4-{[(Benzyloxy)carbonyl]amino}butanoic acid(CAS: 5105-78-2)

4-{[(Benzyloxy)carbonyl]amino}butanoic acid (CAS: 5105-78-2) must comply with the Globally Harmonized System of Classification and Labelling of Chemicals (GHS), REACH regulations in the European Union, and FDA and EPA requirements in the United States. It is classified as a chemical substance that may require registration and reporting under REACH. Specific handling, storage, and disposal guidelines are mandated by these regulations to ensure safety and environmental protection.

Alternatives to 4-{[(Benzyloxy)carbonyl]amino}butanoic acid (CAS: 5105-78-2) in synthesis include similar amino acids or amides with different substituents. Common alternatives include other alpha-amino acids or related compounds with substituents on the side chain. These can be used as precursors or intermediates in various chemical reactions, offering flexibility in synthesis approaches.

The market for 4-{[(Benzyloxy)carbonyl]amino}butanoic acid (CAS: 5105-78-2) is driven by its use in pharmaceuticals, particularly in the development of peptide-based drugs. Research trends focus on its application in medicinal chemistry, where it serves as a building block for synthesizing complex molecules. Market dynamics are influenced by the increasing demand for innovative drug therapies and advancements in synthetic chemistry techniques.

Waste containing 4-{[(Benzyloxy)carbonyl]amino}butanoic acid (CAS: 5105-78-2) should be collected in appropriate containers and stored separately to prevent contamination. For safe disposal, the waste should be treated by incineration or professional waste management services. Environmental protection measures include ensuring the waste is not released into the environment and that the disposal process complies with local and national regulations to minimize ecological impact.